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Abstract 
The management of logistic operations has a very important role in the 
case of pharmaceutical products. The purpose of this article is to analyse the 
particularity of the logistic operations management in the pharmaceutical 
domain. This is seen in the fact that there is the obligativity of using the 
exclusive distribution system, because the carriers do not have selling right 
to the final users. In the pharmaceutical domain, the logistic channels may be 
represented by a system of vertical marketing, made from producers, en-
gross sellers and en-detail sellers that action in the frame of an unified 
system in which a member of the channel may detain property right over the 
other members the vertical marketing system may be corporative or 
contractual. In Romania the medicine producers adopted both marketing 
systems. Organising and distributing medicine from the specialised unities 
(pharmaceutical deposit, close circuit pharmacy or comunitary pharmacy) 
are settled through laws thjat are specific to the pharmaceutical domain. In 
these conditions the mission of the company is to give medicine with a 
balance between price – quality – asureness – eficacity, for giving 
accesibility to different treatments. The role of the state is significant, reason 
for an interdisciplinary approaching that may drive to ideas, oppinions that 
may be aplied. 
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Introduction  
The market for pharmaceutical products must satisfy the order through an 
offer of the producers that realise a restrained gamma of pharmaceutical products 
in big amounts, and the consmers that wish a big gamma of products in small 
amounts. This is the reason why, through the distribution channels, the 
intermediars buy big amount of pharmaceutical products, offering the clients the 
posibility to buy small amounts from the products they wish. The functions of the 
logistic channel do not fundamentally differ from the clasical ones but the problem 
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is who is making them: the producer, or independent distributor. About the 
organisation of the logistic channel –  to the begin of 90s developed vertical 
marketing systems: conventional logistic channel and logistic system for vertical 
marketing. The vertical marketing system may be comanded by the producer, en-
gross or en-detail seller, it might be two types: corporative vertical marketing 
system – all the channel is the property of a single person/brand and contractual 
vertical marketing system – the producers and the distributors are inked between 
through contracts that allow obtaining greater performances and economy then 
acting on their own. These systems created a conflict between the medicine 
producers and the distributors in the U.S.A. The producers serached to increase the 
control over the distribution channels, or by buying a distributor (ex. Merck), or 
making alliances (ex. Pfizer, Bristol Myers Squibb).  
 
Literature review 
The „logistics” term was first used in the military domain (Soare, C., Arsenie, 
V., Barbu, T., Onisor, C. (coord.), Military lexicon, Saka House, 1994), at the 
beginning of the XXth century, the logistics were considered that branch for the 
war art, that moves and provides armies. Step by step, the using of the term 
extended in the economical activity too, as in other domains (Bălan, C., Logistics, 
Uranus House, Bucharest, 2006). Reported to the definitons of the concept, we 
apreciate that the management of the logistics represents a complex of concepts, 
methodes, actions and measures developed with the purpose of assuring the normal 
functionality, eficient and efficacy of the logistic structures in ensemble and in 
detail, and has as a principal purpose touching the objectives, in the condition of 
rational use of resources material, human, financial and other nature that structure 
has (Bălan, C., Logistics, Uranus House, Bucharest, 2006). At an international 
scale, the logistics is a more ample process as implies from the participants a well 
knowing of the settlement and a big flexibility over the settlement of every country. 
The present theme is important because of the increasig ask manifested as 
international as national. The health represents a permanent preocupy as individual 
as statual. The economical situation from the last time period manifests different, 
as country level, but everywhere is observed a comune tendency to reduce as much 
as possible the price of the pharmaceutical products. It is a senzitive aspect to 
quantify because the ask may reach very big amounts in very short time (virosys, 
epidemies), it’s quantification must calculate a serie of aspects as demographical, 
economical, technical, many subjective aspects and last but not least the fact that 
the role of every state is especially important in assuring the protection over the 
health of population. The offertants are industrial producers, small laboratories and 
brands that are part of the logistic chain, such a channel needs a group of 
independent brands (intermediars), implied in the proces of availabling or offering 
services, in the view of use of final purpose.  
To the effectued studies on population segments (consumers of 
pharmaceutical products and services), drove to the fact that at the level of 2010 it 
might be appreciated a far going based on the buying power. So aproximately 70% 
between the beneficiaries of the medico-pharmaceutical assistance in Romania are 
dependent on the public authorities in the district and cosume compensed services 
and products (receipt). Aproximately 20% have mediun incomes  and consume 
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pharmaceutical products and specialty services, mixing the pay system with the 
compensed one. Only 10% of the respondants have over average incomes and can 
afford the payment system. The most important problematic is that of the way in 
which armonising the efforts of all the participants could be realised for obtaining 
an increase in the grade of satisfaction of the consumers in efficient conditions for 
producers and distributors. 
We meet preoccupies for this problematic in the Romanian specialty 
literature about the eficacy of the logistics, and in the abroad literature where an 
interdisciplnary approaching is tried.  
 
The management of logistic operations and the role of the distribution 
channels in the pharmaceutical domain 
Organising and distributing the medicine from the pharmaceutical deposit 
and pharmacy is settled by the Order Of the Ministry of Health no. 201/1999, 
annex 2, cap. II, art. 60-77. The pharmacy is a sanitary unity that has as an activity 
object the prepairing, conserving, sending pharmaceutical products for human use, 
parapharmaceutics, cosmetics, dietetics, stomatological, fitotherapeutical, and 
technico-medical products. The pharmacy functions on the basis of the Order of the 
Ministry of Health no. 201/1999, annex 2, cap. I, art. 1-59. 
In the past years the producers have been exposed too a presion for the price 
and the product portfolio, because of the modifyings in the assurance system for 
health and to the appearance of a new distributors group (ex. „Pharmacy Benefit 
Managers”). These offer advantages in deliverying the medicine, but have made a 
list of medicine the doctors should take in view when give a treatment. For 
example, „Caremark”, an independent american distributor, says that did convince 
in average three out of five doctors to change a medicine that was not on the list 
with one that was written (Bucurescu, S.T., Cuparencu, B., Ponoran, V., Marketing 
for the pharmaceutical industry, Bucharest, Dacia House, 1999). The medicine 
producers must produce medicine depending of their comprehension on the prepaid 
lists, and those who try to maximise their profits see themselves constrained in 
their action by distributors and guvernmental organisms, to maintain the prices to a 
lower level. As a following for this conflict the producer companies switched on 
distribution (ex. „Merck” took over the distribution company „Medco”, 
„SmithKline Beecham” bought the distribution company „Diversified 
Pharmaceutical Services” and „Europharm”, „Pfizer”, ”Rhone-Poulenc Rorer” and 
„Bristol Myers Squibb” signed an accord with „Caremark” for that their products 
to be included on this distributor’s list. In this way, the control over the logistic 
operations allows the producer to win the acces on new market segments and to 
obtain information about the doctor, pharmacist and pacientt, that were not 
included in distributor’s data base.  
Romanian producers that realised the vertical corporative marketing system, 
according to the international uses (producer and angrosist) are: „Antibiotcs” Iasi 
and „Labormed” Bucharest, and those that did not realise this system are 
„Europharm” Brasov and „Pharmatech” Tg. Mures. More of those corelate the 
logistic chain of tthe medicine with that of the information existing a significent 
treespassing between the private district and the public one as can be observed in 
fig. 1. 
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Source: Carata Ana, Management, Marketing and Pharmaceutical Settlement, vol. II, 
Didactical and Pedagogical House, 2000,  p. 132. 
 
Fig. 1. Distribution channels and the circuit of information  
in the pharmaceutical domain 
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For covering the whole Romanian territory a minimum of 13 pharmaceutical 
deposits is recommended, distributed on the whole territory but, depending on the 
efficacy of this web, it may develop in the future.  
 
Logistic of the medicine 
“The en-gros distribution of the medicine, which realizes by the 
pharmaceutical deposits represents the totality of the activities for providing, 
deposit and delivering, without the free activity to the public” (Order no. 
863/28.11.2001 emitted by the Ministry of Health and Family for approving the 
Rules of good practice in distribution for the medicine, Official Monitor, part I no. 
46, 2002, p. 1). The principaly function of  a pharmaceutical deposit is to assure a 
link beetween the medicine producer and pharmacies. The pharmaceutical deposit 
has other important functions too: selling and promoting, contacting, providing 
andd forming the lots, making the goods sellable, deposing, transport, finance, 
taking the risk, informing. The angrosists from the pharmaceutical domain are, 
through nature and tradition, local operators, as a difference from te pharmaceutical 
brands that tent to be global. In the countries where the angrosists have a dominant 
role in the activity of market placing the products, the system of a logistic channel 
has the following characteristics (Bucurescu, S.T., Cuparencu, B., Ponoran, V., 
Marketing for the pharmaceutical industry, Bucharest, Dacia House, 1999):  
 The en-gross sellers tend to open the products to all the producers and to 
delivery them to a specific group of clients (different types of pharmacies). 
Average, almost 80% from the pharmaceutical products’ flux gets to the 
pharmacies through the en-gross sellers; the data varies from a country to another. 
 Analysts and observers prognose that the tendecy of use in an apreciable 
amount of the en-gross sellers in the circulation of medicine thorough the pacient 
will go on in the next years. The number of the en-gorss sellers varies form a 
country to another: in Norway is only onee distributor, in property of the state; in 
Sweden two; three in Finland; between 5 and 280 in the other European Countries.  
 The profits of the en-gross sellers reduced because of the presions the 
gouvernments for decreasing the health fees, private programes for health 
assurances and the increased competers in this district. 
 Increasing the automatisation and using the electronic loading of data, 
billing and stock controling helped en-gross sellers to reduce their costs, 
beneficiars being the pharmacies and the pacients.  
 A strong consolidation of the comerce district is awaiten. A study effectued 
by „Economist Intelligence Unit” (EIU) showed that, except Italy, Japan and Spain, 
the comerce district  in the other countries is domined by two operators (ex.: first 
two operators detain in Germany 45% of the market, 55% in France 65% in 
Canada, 67% in Great Britain, 41% in U.S.A., 80% Holland). 
 Internationalising affects the comerce with pharmaceutical products, so 
many en-gross sellers tried to „europise” their activity through activities and 
alliances (ex. „CERP” Rouen from France bought the brand „SA  DAFRAENE” 
from Belgium and other three en-gross sellers in Spain). 
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 The en-gross comerce with medicine integrates vertically, some en-gross 
sellers started to develop production activities or detail sales. „Unichem” (GB) 
brand produces medicine and opens in detail through „Moss” Brand.  
Because of the great competers many en-gross sellers improve their operation 
through introducing the logistic automat systems, electronically command systems. 
Information from the market allow the en-gross sellers to serve their clients better 
than other competers and to maintain a good link with the market. 
In this sense, analysing the economical evolution of more societies that 
develop contracts in this area we considered signifiant an interesting example, 
SINDAN SRL, that in 2002 was authorized to produce, import, deposit and 
distribute en-gross human medicine. Once with the apperance of the Law no. 
336/2002 the company was broken into two companies, each with a specific 
domain of activity: production, distribution. Is interesting the fact that the incomes 
fromm distribution are bigger than the ones from production (fig. 2). Same 
tendencies have been observed at every analysed brand.  
 
Dis tibution
F abric ation 
 
Source: Internal information of the analysed brand. 
Fig. 2.  Incomes of the brand depending on activities (2009) 
In present the products’ portfolio of SINDAN is composed from 110 
products (aproximately 37% from the business number of the company is 
represented by the production and distribution the left 73%) (fig. 3). 
According to the Rules of Good Distribution and Law about organising and 
using the  National Agency of the Medicine and Ministry of Health (Law no. 
336/2002 about human use medicine), the logistic activity is developing in 
controled conditions, according to the present legislation. The transport is done 
with ways that maintain the medicine in the conditions described by the producer. 
Trasability (the ability of finding the history, apliance or localising what is taken in 
consideration) is a settlement condition and is applied starting from the maintaining 
the recordings from the providing pace.  
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For the eficacy, the societies adopted a new procedure for the reception 
products, deposit, distribution, use of products.  
 
Dis tribution
F abrication
 
Source: Internal information of the company. 
Fig. 3. The number of products parted on activity 
Conclusions 
The medicine represents a special comercial product. Its essence is doube: 
carrier of values that must be taken back through the act of transfer of the property 
and, in the same time, factor that contribues directly to the population health, with 
a special social importance. The logistic function allows the closing between the 
pacient and the medicine and through its’ activities, covers the distance in space 
and time between producer and user, making different treatments possible. 
A first conclusion stains in that the management of logistic operations in the 
pharmaceutical domain represents a particularity, and that the use of exclusive 
distribution system. Another conclusion is that the producers from the 
pharmaceutical industry realise a restrained number of products adressed to special 
needs consumers, that’s why the responsibilities might be bigger than in the case of 
other products and services. In these conditions authorising more products in the 
sight of sending on the internal and external market and extending the distribution 
lines would be benefic.  
The delivery system is organised so as every client is served in the least 24 
hours. A part from the clients are served in 12 hours the emergency orders could be 
served in 4 hours. In these conditions the time and price factor may be sustained 
through adopting the unitized systems of some mini-containers built with 
international standard dimensions. The pays are reduced with the cover, the risks of 
losing or breaking through carrying are reduced, and the time for executing the 
transport reduces to half. Adopting the concept of logistic integrated management, 
offering some better services to the clients and reducing the pays for distribution, 
needs team work, inside the brand and with all the organisations that realize the 
logistic channel (Kotler, Armstrong, The principles of marketing, Bucharest, Teora 
Publishing House, 2004, p. 615).  
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